美国生物技术公司莫德纳（Moderna, Inc.）股价在周三盘后交易中大幅下跌6.44%，投资者对即将举行的美国食品和药物管理局（FDA）会议反应强烈。
据报道，FDA将于5月22日召开专家会议，讨论COVID-19疫苗对即将开展的免疫接种活动的建议。这一消息引发了市场对莫德纳等疫苗生产商未来销售前景的担忧。值得注意的是，此次会议是在新任FDA局长马丁·马卡里（Martin Makary）上任后召开的。马卡里此前曾对COVID-19大流行期间的某些公共卫生措施表示担忧，并反对强制公众接种疫苗。
此外，FDA近期进行的大规模裁员也引发了业界对药品和疫苗监管审查可能中断的担忧。这些因素叠加在一起，增加了莫德纳等制药公司面临的监管不确定性，可能是导致其股价大幅下跌的主要原因。投资者将密切关注即将举行的FDA会议结果，以评估其对莫德纳等疫苗生产商未来业务的潜在影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.